Established Brands Optimization Strategy Overview

This document is a fact sheet detailing the Established Brands Optimization (EBO) strategy by IQVIA. It outlines the challenges faced by established brands in the pharmaceutical sector, which account for over 60% of global pharma sales. Key pressures include the loss of exclusivity for numerous products, increased competition, and evolving regulatory demands, which contribute to significant risks in revenue. The document identifies four major levers that can revitalize brand performance: enhancing sales and revenues, managing portfolio complexity, driving net revenues, and optimizing operational spend. It presents a modular approach that combines data, technology, and execution to deliver tailored commercial impact. The EBO strategy aims to protect and grow the value of established products through strategic consulting and opportunity assessment, leveraging IQVIA's global capabilities and analytics. Case studies illustrate the successful application of this strategy across various clients, demonstrating its effectiveness in addressing sales erosion and improving market engagement.